NEOMIB
Brand Name: NEOMIB
Generic Name: Bortezomib
Active
Registration Number
DRP-5513
Dosage Form
Lyophilized Powder For Injection
Issuance Date
March 1, 2024
Expiry Date
September 15, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength3.5 mg
PackagingType I Flint Transparent Tubular Glass Vial x 15mL (Box of 1's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
BortezomibActive
Monograph: Bortezomib